Predictors of knowledge of and access to biomedical prevention among MSM and transgender men in Latin America: Results from the Latin American internet survey

Imagem de Miniatura
Arquivos
art_AVELINO-SILVA_Predictors_of_knowledge_of_and_access_to_biomedical_2022.PDF (1.03 MB)
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2022
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
MARCUS, Ulrich
SCHMIDT, Axel Jeremias
VERAS, Maria Amelia
Citação
HIV MEDICINE, v.23, n.7, p.764-773, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Introduction HIV is still a central public health issue in Latin America, disproportionally affecting key populations. Knowledge and access to biomedical prevention strategies, including treatment as prevention (TASP) or undetectable = untransmissible (U=U), pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP), are the first steps to increasing uptake. We used data from the Latin American MSM Internet Survey (LAMIS) to describe knowledge and access to biomedical HIV prevention strategies among gay, bisexual, transgender and other men who have sex with men (MSM) living in 18 Latin American countries. Methods We compared LAMIS data across countries and according to age categories using frequencies and percentages. We also used multivariable models to explore whether age, gender identity, sexual identity, steady partnership, HIV status and education were independently associated with outcomes. Results In all, 55 924 participants were included. Most were cisgender (99%) and identified as gay/homosexual (77%) or bisexual (17%). Schooling levels were very high, with 89% reporting highest attained education as tertiary level, university or post-graduation. In total, 16% had been previously diagnosed with HIV; of those, rates of undetectable viral load varied from 60% in Venezuela to 83% in Brazil. Overall, 54%, 54% and 52% of participants already knew about PEP, PrEP and U=U, respectively. Participants from Brazil and those aged between 26 and 55 years, living with diagnosed HIV and having a gay/homosexual identity had greater levels of awareness about biomedical prevention strategies. Conclusions Our study highlights gaps in HIV prevention campaigns directed to MSM in Latin America resulting in low uptake of biomedical prevention methods.
Palavras-chave
highly active antiretroviral therapy, post-exposure prophylaxis, pre-exposure prophylaxis, sexual and gender minorities, transgender persons, undetectable = untransmissible
URI
https://observatorio.fm.usp.br/handle/OPI/48424
Referências
  1. [Anonymous], 2020, UNAIDS DATA
  2. Bastos FI, 2008, INT J EPIDEMIOL, V37, P729, DOI 10.1093/ije/dyn127
  3. Bautista-Arredondo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072616
  4. Caceres CF, 2003, INT J EPIDEMIOL, V32, P740, DOI 10.1093/ije/dyg214
  5. Coelho LE, 2021, AIDS BEHAV, V25, P3223, DOI 10.1007/s10461-021-03180-5
  6. De Boni R, 2014, CURR OPIN HIV AIDS, V9, P192, DOI 10.1097/COH.0000000000000031
  7. Frenk J, 2018, ARCH MED RES, V49, P79, DOI 10.1016/j.arcmed.2018.06.002
  8. Garcia PJ, 2014, CURR HIV-AIDS REP, V11, P146, DOI 10.1007/s11904-014-0204-1
  9. Kerr L, 2018, MEDICINE, V97, pS9, DOI [10.1097/MD.0000000000010573, 10.1097/md.0000000000010573]
  10. Kerr LRFS, 2013, AIDS, V27, P427, DOI 10.1097/QAD.0b013e32835ad504
  11. Levi J, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2015-000010
  12. Luz PM, 2019, CURR OPIN HIV AIDS, V14, P366, DOI 10.1097/COH.0000000000000564
  13. Matacotta JJ, 2020, J PATIENT-CENTER RES, V7, P265, DOI 10.17294/2330-0698.1737
  14. Sousa LRM, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-020-10135-3
  15. Miller WM, 2013, SALUD PUBLICA MEXICO, V55, pS65
  16. Ngure K, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25466
  17. Nunes NN., 2020, 12 C PAUL INF
  18. Siegel K, 2019, AIDS BEHAV, V23, P1974, DOI 10.1007/s10461-019-02405-y
  19. The EMIS Network,, 2019, EMIS 2017 EUR MEN WH
  20. Torres TS, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25630
  21. Torres TS, 2019, AIDS CARE, V31, P1193, DOI 10.1080/09540121.2019.1619665
  22. Torres TS, 2019, JMIR PUBLIC HLTH SUR, V5, P177, DOI 10.2196/13771
  23. Vergara-Ortega DN, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-06582-x
  24. Weatherburn P, 2020, SEX RES SOC POLICY, V17, P543, DOI 10.1007/s13178-019-00413-0
  25. Weatherburn P, 2013, SEX RES SOC POLICY, V10, P243, DOI 10.1007/s13178-013-0119-4
  26. Winter S, 2016, LANCET, V388, P390, DOI 10.1016/S0140-6736(16)00683-8
  27. Yi S, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21580
  28. Zea MC, 2015, AM J PUBLIC HEALTH, V105, P1588, DOI 10.2105/AJPH.2014.302307
  29. Zeeman L, 2019, EUR J PUBLIC HEALTH, V29, P974, DOI 10.1093/eurpub/cky226

Coleções
Artigos e Materiais de Revistas Científicas - FM/MIP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/49
Artigos e Materiais de Revistas Científicas - ODS/03
Artigos e Materiais de Revistas Científicas - ODS/05